0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical CMO Services Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-25O5716
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical CMO Services Market Insights Forecast to 2028
BUY CHAPTERS

Global Pharmaceutical CMO Services Market Research Report 2025

Code: QYRE-Auto-25O5716
Report
July 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical CMO Services Market

The global market for Pharmaceutical CMO Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
In terms of regions, North America is expected to remain the largest market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical CMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CMO Services.
The Pharmaceutical CMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical CMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical CMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmaceutical CMO Services Market Report

Report Metric Details
Report Name Pharmaceutical CMO Services Market
Segment by Type
  • Active Pharmaceutical Ingredients (APIs)
  • Finished Dose Formulations (FDFs)
Segment by Application
  • Pharmaceutical Industry
  • Biotechnology Industry
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, Recipharm, Aenova, AbbVie, Baxter, Nipro Corp, Sopharma, Famar, Vetter, Shandong Xinhua, Piramal, Mylan, Dr. Reddy’s, Zhejiang Hisun, Zhejiang Huahai, Jubilant
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmaceutical CMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical CMO Services Market report?

Ans: The main players in the Pharmaceutical CMO Services Market are Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, Recipharm, Aenova, AbbVie, Baxter, Nipro Corp, Sopharma, Famar, Vetter, Shandong Xinhua, Piramal, Mylan, Dr. Reddy’s, Zhejiang Hisun, Zhejiang Huahai, Jubilant

What are the Application segmentation covered in the Pharmaceutical CMO Services Market report?

Ans: The Applications covered in the Pharmaceutical CMO Services Market report are Pharmaceutical Industry, Biotechnology Industry

What are the Type segmentation covered in the Pharmaceutical CMO Services Market report?

Ans: The Types covered in the Pharmaceutical CMO Services Market report are Active Pharmaceutical Ingredients (APIs), Finished Dose Formulations (FDFs)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical CMO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Active Pharmaceutical Ingredients (APIs)
1.2.3 Finished Dose Formulations (FDFs)
1.3 Market by Application
1.3.1 Global Pharmaceutical CMO Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Industry
1.3.3 Biotechnology Industry
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical CMO Services Market Perspective (2020-2031)
2.2 Global Pharmaceutical CMO Services Growth Trends by Region
2.2.1 Global Pharmaceutical CMO Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical CMO Services Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical CMO Services Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical CMO Services Market Dynamics
2.3.1 Pharmaceutical CMO Services Industry Trends
2.3.2 Pharmaceutical CMO Services Market Drivers
2.3.3 Pharmaceutical CMO Services Market Challenges
2.3.4 Pharmaceutical CMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical CMO Services Players by Revenue
3.1.1 Global Top Pharmaceutical CMO Services Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical CMO Services Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical CMO Services Revenue
3.4 Global Pharmaceutical CMO Services Market Concentration Ratio
3.4.1 Global Pharmaceutical CMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CMO Services Revenue in 2024
3.5 Global Key Players of Pharmaceutical CMO Services Head office and Area Served
3.6 Global Key Players of Pharmaceutical CMO Services, Product and Application
3.7 Global Key Players of Pharmaceutical CMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical CMO Services Breakdown Data by Type
4.1 Global Pharmaceutical CMO Services Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical CMO Services Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical CMO Services Breakdown Data by Application
5.1 Global Pharmaceutical CMO Services Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical CMO Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical CMO Services Market Size (2020-2031)
6.2 North America Pharmaceutical CMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical CMO Services Market Size by Country (2020-2025)
6.4 North America Pharmaceutical CMO Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical CMO Services Market Size (2020-2031)
7.2 Europe Pharmaceutical CMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical CMO Services Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical CMO Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical CMO Services Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical CMO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical CMO Services Market Size (2020-2031)
9.2 Latin America Pharmaceutical CMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical CMO Services Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical CMO Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical CMO Services Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical CMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Pharmaceutical CMO Services Introduction
11.1.4 Catalent Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.1.5 Catalent Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Pharmaceutical CMO Services Introduction
11.2.4 Thermo Fisher Scientific Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Pharmaceutical CMO Services Introduction
11.3.4 Lonza Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.3.5 Lonza Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Pharmaceutical CMO Services Introduction
11.4.4 Boehringer Ingelheim Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Fareva
11.5.1 Fareva Company Details
11.5.2 Fareva Business Overview
11.5.3 Fareva Pharmaceutical CMO Services Introduction
11.5.4 Fareva Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.5.5 Fareva Recent Development
11.6 Recipharm
11.6.1 Recipharm Company Details
11.6.2 Recipharm Business Overview
11.6.3 Recipharm Pharmaceutical CMO Services Introduction
11.6.4 Recipharm Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.6.5 Recipharm Recent Development
11.7 Aenova
11.7.1 Aenova Company Details
11.7.2 Aenova Business Overview
11.7.3 Aenova Pharmaceutical CMO Services Introduction
11.7.4 Aenova Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.7.5 Aenova Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Pharmaceutical CMO Services Introduction
11.8.4 AbbVie Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.8.5 AbbVie Recent Development
11.9 Baxter
11.9.1 Baxter Company Details
11.9.2 Baxter Business Overview
11.9.3 Baxter Pharmaceutical CMO Services Introduction
11.9.4 Baxter Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.9.5 Baxter Recent Development
11.10 Nipro Corp
11.10.1 Nipro Corp Company Details
11.10.2 Nipro Corp Business Overview
11.10.3 Nipro Corp Pharmaceutical CMO Services Introduction
11.10.4 Nipro Corp Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.10.5 Nipro Corp Recent Development
11.11 Sopharma
11.11.1 Sopharma Company Details
11.11.2 Sopharma Business Overview
11.11.3 Sopharma Pharmaceutical CMO Services Introduction
11.11.4 Sopharma Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.11.5 Sopharma Recent Development
11.12 Famar
11.12.1 Famar Company Details
11.12.2 Famar Business Overview
11.12.3 Famar Pharmaceutical CMO Services Introduction
11.12.4 Famar Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.12.5 Famar Recent Development
11.13 Vetter
11.13.1 Vetter Company Details
11.13.2 Vetter Business Overview
11.13.3 Vetter Pharmaceutical CMO Services Introduction
11.13.4 Vetter Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.13.5 Vetter Recent Development
11.14 Shandong Xinhua
11.14.1 Shandong Xinhua Company Details
11.14.2 Shandong Xinhua Business Overview
11.14.3 Shandong Xinhua Pharmaceutical CMO Services Introduction
11.14.4 Shandong Xinhua Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.14.5 Shandong Xinhua Recent Development
11.15 Piramal
11.15.1 Piramal Company Details
11.15.2 Piramal Business Overview
11.15.3 Piramal Pharmaceutical CMO Services Introduction
11.15.4 Piramal Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.15.5 Piramal Recent Development
11.16 Mylan
11.16.1 Mylan Company Details
11.16.2 Mylan Business Overview
11.16.3 Mylan Pharmaceutical CMO Services Introduction
11.16.4 Mylan Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.16.5 Mylan Recent Development
11.17 Dr. Reddy’s
11.17.1 Dr. Reddy’s Company Details
11.17.2 Dr. Reddy’s Business Overview
11.17.3 Dr. Reddy’s Pharmaceutical CMO Services Introduction
11.17.4 Dr. Reddy’s Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.17.5 Dr. Reddy’s Recent Development
11.18 Zhejiang Hisun
11.18.1 Zhejiang Hisun Company Details
11.18.2 Zhejiang Hisun Business Overview
11.18.3 Zhejiang Hisun Pharmaceutical CMO Services Introduction
11.18.4 Zhejiang Hisun Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.18.5 Zhejiang Hisun Recent Development
11.19 Zhejiang Huahai
11.19.1 Zhejiang Huahai Company Details
11.19.2 Zhejiang Huahai Business Overview
11.19.3 Zhejiang Huahai Pharmaceutical CMO Services Introduction
11.19.4 Zhejiang Huahai Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.19.5 Zhejiang Huahai Recent Development
11.20 Jubilant
11.20.1 Jubilant Company Details
11.20.2 Jubilant Business Overview
11.20.3 Jubilant Pharmaceutical CMO Services Introduction
11.20.4 Jubilant Revenue in Pharmaceutical CMO Services Business (2020-2025)
11.20.5 Jubilant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pharmaceutical CMO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Active Pharmaceutical Ingredients (APIs)
 Table 3. Key Players of Finished Dose Formulations (FDFs)
 Table 4. Global Pharmaceutical CMO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pharmaceutical CMO Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharmaceutical CMO Services Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pharmaceutical CMO Services Market Share by Region (2020-2025)
 Table 8. Global Pharmaceutical CMO Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pharmaceutical CMO Services Market Share by Region (2026-2031)
 Table 10. Pharmaceutical CMO Services Market Trends
 Table 11. Pharmaceutical CMO Services Market Drivers
 Table 12. Pharmaceutical CMO Services Market Challenges
 Table 13. Pharmaceutical CMO Services Market Restraints
 Table 14. Global Pharmaceutical CMO Services Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pharmaceutical CMO Services Market Share by Players (2020-2025)
 Table 16. Global Top Pharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CMO Services as of 2024)
 Table 17. Ranking of Global Top Pharmaceutical CMO Services Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pharmaceutical CMO Services Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pharmaceutical CMO Services, Headquarters and Area Served
 Table 20. Global Key Players of Pharmaceutical CMO Services, Product and Application
 Table 21. Global Key Players of Pharmaceutical CMO Services, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pharmaceutical CMO Services Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pharmaceutical CMO Services Revenue Market Share by Type (2020-2025)
 Table 25. Global Pharmaceutical CMO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pharmaceutical CMO Services Revenue Market Share by Type (2026-2031)
 Table 27. Global Pharmaceutical CMO Services Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pharmaceutical CMO Services Revenue Market Share by Application (2020-2025)
 Table 29. Global Pharmaceutical CMO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pharmaceutical CMO Services Revenue Market Share by Application (2026-2031)
 Table 31. North America Pharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pharmaceutical CMO Services Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pharmaceutical CMO Services Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pharmaceutical CMO Services Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pharmaceutical CMO Services Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pharmaceutical CMO Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pharmaceutical CMO Services Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pharmaceutical CMO Services Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Catalent Company Details
 Table 47. Catalent Business Overview
 Table 48. Catalent Pharmaceutical CMO Services Product
 Table 49. Catalent Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 50. Catalent Recent Development
 Table 51. Thermo Fisher Scientific Company Details
 Table 52. Thermo Fisher Scientific Business Overview
 Table 53. Thermo Fisher Scientific Pharmaceutical CMO Services Product
 Table 54. Thermo Fisher Scientific Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 55. Thermo Fisher Scientific Recent Development
 Table 56. Lonza Company Details
 Table 57. Lonza Business Overview
 Table 58. Lonza Pharmaceutical CMO Services Product
 Table 59. Lonza Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 60. Lonza Recent Development
 Table 61. Boehringer Ingelheim Company Details
 Table 62. Boehringer Ingelheim Business Overview
 Table 63. Boehringer Ingelheim Pharmaceutical CMO Services Product
 Table 64. Boehringer Ingelheim Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 65. Boehringer Ingelheim Recent Development
 Table 66. Fareva Company Details
 Table 67. Fareva Business Overview
 Table 68. Fareva Pharmaceutical CMO Services Product
 Table 69. Fareva Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 70. Fareva Recent Development
 Table 71. Recipharm Company Details
 Table 72. Recipharm Business Overview
 Table 73. Recipharm Pharmaceutical CMO Services Product
 Table 74. Recipharm Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 75. Recipharm Recent Development
 Table 76. Aenova Company Details
 Table 77. Aenova Business Overview
 Table 78. Aenova Pharmaceutical CMO Services Product
 Table 79. Aenova Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 80. Aenova Recent Development
 Table 81. AbbVie Company Details
 Table 82. AbbVie Business Overview
 Table 83. AbbVie Pharmaceutical CMO Services Product
 Table 84. AbbVie Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 85. AbbVie Recent Development
 Table 86. Baxter Company Details
 Table 87. Baxter Business Overview
 Table 88. Baxter Pharmaceutical CMO Services Product
 Table 89. Baxter Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 90. Baxter Recent Development
 Table 91. Nipro Corp Company Details
 Table 92. Nipro Corp Business Overview
 Table 93. Nipro Corp Pharmaceutical CMO Services Product
 Table 94. Nipro Corp Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 95. Nipro Corp Recent Development
 Table 96. Sopharma Company Details
 Table 97. Sopharma Business Overview
 Table 98. Sopharma Pharmaceutical CMO Services Product
 Table 99. Sopharma Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 100. Sopharma Recent Development
 Table 101. Famar Company Details
 Table 102. Famar Business Overview
 Table 103. Famar Pharmaceutical CMO Services Product
 Table 104. Famar Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 105. Famar Recent Development
 Table 106. Vetter Company Details
 Table 107. Vetter Business Overview
 Table 108. Vetter Pharmaceutical CMO Services Product
 Table 109. Vetter Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 110. Vetter Recent Development
 Table 111. Shandong Xinhua Company Details
 Table 112. Shandong Xinhua Business Overview
 Table 113. Shandong Xinhua Pharmaceutical CMO Services Product
 Table 114. Shandong Xinhua Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 115. Shandong Xinhua Recent Development
 Table 116. Piramal Company Details
 Table 117. Piramal Business Overview
 Table 118. Piramal Pharmaceutical CMO Services Product
 Table 119. Piramal Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 120. Piramal Recent Development
 Table 121. Mylan Company Details
 Table 122. Mylan Business Overview
 Table 123. Mylan Pharmaceutical CMO Services Product
 Table 124. Mylan Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 125. Mylan Recent Development
 Table 126. Dr. Reddy’s Company Details
 Table 127. Dr. Reddy’s Business Overview
 Table 128. Dr. Reddy’s Pharmaceutical CMO Services Product
 Table 129. Dr. Reddy’s Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 130. Dr. Reddy’s Recent Development
 Table 131. Zhejiang Hisun Company Details
 Table 132. Zhejiang Hisun Business Overview
 Table 133. Zhejiang Hisun Pharmaceutical CMO Services Product
 Table 134. Zhejiang Hisun Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 135. Zhejiang Hisun Recent Development
 Table 136. Zhejiang Huahai Company Details
 Table 137. Zhejiang Huahai Business Overview
 Table 138. Zhejiang Huahai Pharmaceutical CMO Services Product
 Table 139. Zhejiang Huahai Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 140. Zhejiang Huahai Recent Development
 Table 141. Jubilant Company Details
 Table 142. Jubilant Business Overview
 Table 143. Jubilant Pharmaceutical CMO Services Product
 Table 144. Jubilant Revenue in Pharmaceutical CMO Services Business (2020-2025) & (US$ Million)
 Table 145. Jubilant Recent Development
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources
 Table 149. Authors List of This Report


List of Figures
 Figure 1. Pharmaceutical CMO Services Picture
 Figure 2. Global Pharmaceutical CMO Services Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceutical CMO Services Market Share by Type: 2024 VS 2031
 Figure 4. Active Pharmaceutical Ingredients (APIs) Features
 Figure 5. Finished Dose Formulations (FDFs) Features
 Figure 6. Global Pharmaceutical CMO Services Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pharmaceutical CMO Services Market Share by Application: 2024 VS 2031
 Figure 8. Pharmaceutical Industry Case Studies
 Figure 9. Biotechnology Industry Case Studies
 Figure 10. Pharmaceutical CMO Services Report Years Considered
 Figure 11. Global Pharmaceutical CMO Services Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Pharmaceutical CMO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pharmaceutical CMO Services Market Share by Region: 2024 VS 2031
 Figure 14. Global Pharmaceutical CMO Services Market Share by Players in 2024
 Figure 15. Global Top Pharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CMO Services as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Pharmaceutical CMO Services Revenue in 2024
 Figure 17. North America Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Pharmaceutical CMO Services Market Share by Country (2020-2031)
 Figure 19. United States Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Pharmaceutical CMO Services Market Share by Country (2020-2031)
 Figure 23. Germany Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Pharmaceutical CMO Services Market Share by Region (2020-2031)
 Figure 31. China Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Pharmaceutical CMO Services Market Share by Country (2020-2031)
 Figure 39. Mexico Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Pharmaceutical CMO Services Market Share by Country (2020-2031)
 Figure 43. Turkey Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Pharmaceutical CMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Catalent Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 48. Lonza Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 49. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 50. Fareva Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 51. Recipharm Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 52. Aenova Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 53. AbbVie Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 54. Baxter Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 55. Nipro Corp Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 56. Sopharma Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 57. Famar Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 58. Vetter Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 59. Shandong Xinhua Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 60. Piramal Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 61. Mylan Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 62. Dr. Reddy’s Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 63. Zhejiang Hisun Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 64. Zhejiang Huahai Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 65. Jubilant Revenue Growth Rate in Pharmaceutical CMO Services Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart